Pivotal data for the investigational treatment PSD502 for primary premature ejaculation
Monday, May 31, 2010 - 23:40
in Health & Medicine
SAN FRANCISCO, CA/ATLANTA, GA, June 1, 2010 – Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies...